LW
Lewis T Williams
Director

Lewis T Williams insider trades: Protagonist Therapeutics (PTGX) stock sales

Director, Protagonist Therapeutics Last trade Feb 17, 2026 66 Form 4 filings
$1.5M
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2014
5
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Lewis reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 17, 2026PTGX↓ Sell$1.5M
Dec 23, 2016FPRX↓ Sell$1.5M
Apr 21, 2016FPRX↓ Sell$2.3M
Apr 15, 2016FPRX↓ Sell$67K
Apr 14, 2016FPRX↓ Sell$131K
Apr 6, 2016FPRX↓ Sell$2.3M
Mar 30, 2016FPRX↓ Sell$931K
Mar 2, 2016FPRX↓ Sell$838K
Feb 4, 2016FPRX↓ Sell$2.4M
Oct 15, 2015FPRX↓ Sell$2.0M
Sep 21, 2015FPRX↓ Sell$58K
Jun 22, 2015FPRX↓ Sell$1.9M
Nov 4, 2014FPRX↓ Sell$426K
Oct 30, 2014FPRX↓ Sell$228K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PTGX insiders

Open-market trades in the last 12 months

About Lewis T Williams's insider trades

Lewis T Williams is a director at Protagonist Therapeutics (PTGX). Since Oct 30, 2014, Lewis has reported no open-market purchases and 14 sales worth $16.5M on SEC Form 4. In the last 12 months: 1 sale ($1.5M).

Their filings also include grants and awards (36 filings), option exercises (11 filings), shares withheld for taxes (9 filings), gifts (5 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PTGX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.